BIO Patient Advocacy Coffee Chat The Future of Cures… and Coverage: Cell and Gene Therapies Wednesday, October 4, 2023 2:00 pm – 3:00 pm ET Please join us for a chat about the science behind gene and cell therapies, and the challenges patients face in accessing these therapies. The recently proposed CMS MDRP rule presents serious concerns around patient access, and adds complexity to the already onerous path Medicaid patients face when it comes to accessing promising new therapies.    Speakers: Hanna Zaghloul, PharmD – Medical Science Liaison US Medical Hematology and Cell Therapy, Bristol Myers Squibb Jonathan Liu, MD – Global Program Medical Director, Hemophilia | Gene Therapy, BioMarin Kristin Viswanathan Wolff, MPH – Vice President, Market Access, bluebird bio Moderated by Michele Oshman – Vice President, BIO External Affairs Register Here! You must register to receive the link and dial-in information